380 related articles for article (PubMed ID: 9819212)
1. Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen.
Pasternak A; Liu X; Lin TY; Hedstrom L
Biochemistry; 1998 Nov; 37(46):16201-10. PubMed ID: 9819212
[TBL] [Abstract][Full Text] [Related]
2. The energetic cost of induced fit catalysis: Crystal structures of trypsinogen mutants with enhanced activity and inhibitor affinity.
Pasternak A; White A; Jeffery CJ; Medina N; Cahoon M; Ringe D; Hedstrom L
Protein Sci; 2001 Jul; 10(7):1331-42. PubMed ID: 11420435
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases.
Hedstrom L; Lin TY; Fast W
Biochemistry; 1996 Apr; 35(14):4515-23. PubMed ID: 8605201
[TBL] [Abstract][Full Text] [Related]
4. Comparison of anionic and cationic trypsinogens: the anionic activation domain is more flexible in solution and differs in its mode of BPTI binding in the crystal structure.
Pasternak A; Ringe D; Hedstrom L
Protein Sci; 1999 Jan; 8(1):253-8. PubMed ID: 10210204
[TBL] [Abstract][Full Text] [Related]
5. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
6. Ligand-induced changes in the conformational stability of bovine trypsinogen and their implications for the protein function.
Bulaj G; Otlewski J
J Mol Biol; 1995 Apr; 247(4):701-16. PubMed ID: 7723025
[TBL] [Abstract][Full Text] [Related]
7. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein.
Munagala NR; Wang CC
Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428
[TBL] [Abstract][Full Text] [Related]
8. Probing conformational plasticity of the activation domain of trypsin: the role of glycine hinges.
Gombos L; Kardos J; Patthy A; Medveczky P; Szilágyi L; Málnási-Csizmadia A; Gráf L
Biochemistry; 2008 Feb; 47(6):1675-84. PubMed ID: 18193894
[TBL] [Abstract][Full Text] [Related]
9. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis?
Sahin-Tóth M; Gráf L; Tóth M
Biochem Biophys Res Commun; 1999 Oct; 264(2):505-8. PubMed ID: 10529393
[TBL] [Abstract][Full Text] [Related]
10. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
Krokoszynska I; Dadlez M; Otlewski J
J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
[TBL] [Abstract][Full Text] [Related]
11. High-level bacterial expression and 15N-alanine-labeling of bovine trypsin. Application to the study of trypsin-inhibitor complexes and trypsinogen activation by NMR spectroscopy.
Peterson FC; Gordon NC; Gettins PG
Biochemistry; 2001 May; 40(21):6275-83. PubMed ID: 11371189
[TBL] [Abstract][Full Text] [Related]
12. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
13. Mutant rat trypsin selectively cleaves tyrosyl peptide bonds.
Pál G; Patthy A; Antal J; Gráf L
Anal Biochem; 2004 Mar; 326(2):190-9. PubMed ID: 15003560
[TBL] [Abstract][Full Text] [Related]
14. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
15. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.
Sahin-Tóth M
J Biol Chem; 2000 Jul; 275(30):22750-5. PubMed ID: 10801865
[TBL] [Abstract][Full Text] [Related]
16. [Significance of trypsinogen gene mutations in the etiology of hereditary pancreatitis].
Sahin-Tóth M; Tóth M
Orv Hetil; 2001 Mar; 142(12):603-6. PubMed ID: 11324217
[TBL] [Abstract][Full Text] [Related]
17. Evolution of trypsinogen activation peptides.
Chen JM; Kukor Z; Le Maréchal C; Tóth M; Tsakiris L; Raguénès O; Férec C; Sahin-Tóth M
Mol Biol Evol; 2003 Nov; 20(11):1767-77. PubMed ID: 12832630
[TBL] [Abstract][Full Text] [Related]
18. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
Lu D; Fütterer K; Korolev S; Zheng X; Tan K; Waksman G; Sadler JE
J Mol Biol; 1999 Sep; 292(2):361-73. PubMed ID: 10493881
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen exchange kinetics of bovine pancreatic trypsin inhibitor beta-sheet protons in trypsin-bovine pancreatic trypsin inhibitor, trypsinogen-bovine pancreatic trypsin inhibitor, and trypsinogen-isoleucylvaline-bovine pancreatic trypsin inhibitor.
Brandt P; Woodward C
Biochemistry; 1987 Jun; 26(11):3156-67. PubMed ID: 2440473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
